Feed Insights Top Reports Pricing

⌘K

22:12:00·1140d

PRReleasevia Quantisnow

Valaris Reports First Quarter 2023 Results

ByQuantisnow·Wall Street's wire, on your screen.

VAL· Valaris Limited

Energy

Plus alert sent

Quantisnow Plus members were alerted at 22:12:00 ET - 0.8s after publication.

Sign up for Plus

Free Quantisnow account

Get notified the moment VAL files

Real-time alerts on SEC filings, FDA approvals, analyst ratings, insider trades, and press releases. Follow any ticker. No credit card.

Sign up free Log in

This insight was delivered by Quantisnow - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VAL (Valaris Limited) and more on Quantisnow.

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Related

Director Hughes Catherine was granted 2,493 shares and covered exercise/tax liability with 397 shares, increasing direct ownership by 16% to 15,448 units (SEC Form 4) (withholding obligation)
Director Leykum Elizabeth converted options into 6,978 shares and returned $248,432 worth of shares to the company (2,792 units at $88.98), increasing direct ownership by 11% to 43,019 units (SEC Form 4)
Director Johansen Kristian returned $172,977 worth of shares to the company (1,944 units at $88.98), was granted 1,984 shares and converted options into 4,860 shares, increasing direct ownership by 105% to 9,548 units (SEC Form 4)
SEC Form 4 filed by Director Fagerstal Dick
Director Goldschmid Joseph was granted 2,188 shares (SEC Form 4)

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releases Analyst ratings Insider trading FDA SEC RSS feeds Follow on Google News

Top lists

Trending By market cap Active companies Insider purchases FDA approvals Short volume screener Sectors Market reports

Browse

By event category By exchange Earnings calendar Dividend tracker Insider tracker IPO calendar Compare stocks

Publish

Publish an article Amend a newsitem Pricing Guidelines Terms

Company

About Pricing Refer a trader25%Publish with us Contact

Legal

Terms of use Privacy policy Cookie policy

© 2026 quantisnow.com · Democratizing insights since 2022